These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
934 related articles for article (PubMed ID: 3126240)
21. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088 [TBL] [Abstract][Full Text] [Related]
22. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells. Saxena RK; Saxena QB; Adler WH J Immunol; 1988 Sep; 141(5):1782-7. PubMed ID: 2457628 [TBL] [Abstract][Full Text] [Related]
23. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Reiter Z Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640 [TBL] [Abstract][Full Text] [Related]
24. Lysis of human solid tumor cells by lymphokine-activated natural killer cells. Itoh K; Tilden AB; Balch CM J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648 [TBL] [Abstract][Full Text] [Related]
25. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells. Johnson PW; Trimble WS; Hozumi N; Roder JC J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578 [TBL] [Abstract][Full Text] [Related]
26. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression. Brutkiewicz RR; Klaus SJ; Welsh RM Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956 [TBL] [Abstract][Full Text] [Related]
27. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. Karlhofer FM; Yokoyama WM J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886 [TBL] [Abstract][Full Text] [Related]
28. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980 [TBL] [Abstract][Full Text] [Related]
29. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related]
30. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569 [TBL] [Abstract][Full Text] [Related]
31. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]
32. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells. Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624 [TBL] [Abstract][Full Text] [Related]
33. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes. Itoh T; Storkus WJ; Gorelik E; Lotze MT J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974 [TBL] [Abstract][Full Text] [Related]
34. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
35. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Ma D; Luyten GP; Luider TM; Niederkorn JY Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912 [TBL] [Abstract][Full Text] [Related]
36. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534 [TBL] [Abstract][Full Text] [Related]
37. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene. Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes. Li M; Muller J; Xu F; Hearing VJ; Gorelik E Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142 [TBL] [Abstract][Full Text] [Related]
39. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV; Welsh RM; Haspel MV J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198 [TBL] [Abstract][Full Text] [Related]
40. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells. Fresa KL; Karjalainen HE; Tevethia SS J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]